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This data article presents an analysis of structural water molecules in
the high afﬁnity interaction between a potent tumor growth inhibiting
antibody (fragment), J22.9-xi, and the tumor marker antigen CD269 (B
cell maturation antigen, BCMA). The 1.89
Â
e X-ray crystal structure
shows exquisite details of the binding interface between the two
molecules, which comprises relatively few, mostly hydrophobic, direct
contacts but many indirect interactions over solvent waters. These are
partly or wholly buried in, and therefore part of, the interface. A partial
description of the structure is included in an article on the tumor
inhibiting effects of the antibody: “Potent anti-tumor response by
targeting B cell maturation antigen (BCMA) in a mouse model of
multiple myeloma”, Mol. Oncol. 9 (7) (2015) pp. 1348–58.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Chemistry, Biology, Cancer immunology
ore speciﬁc sub-
ject areaStructural biologyype of data Parameter table for structurally observed water molecules; ﬁgures depicting
positions of these waters in a binding interfaceow data was
acquiredAnalysis of the reﬁned X-ray crystallographic structure.ata format Table, ﬁgures.vier Inc. This is an open access article under the CC BY license
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factors1. Water molecules in
able domains of the heav
rogen bonding interactio
e interface residues (wi
eres) are labeled. Leu17
ding cavity in J22.9-xi w
red blue and the light
ws and darker coloring.Fab fragments from anti-CD269 (BCMA) IgGs co-crystallized with antigen and
the structure solved to high (1.89
Â
e) resolutionxperimental
featuresInterface interactions in the reﬁned structure were assessed and the contribution
of water to the binding evaluated.ata source
locationProtein Data Bankata accessibility 〈http://www.rcsb.org/pdb/home/home.do〉 (PDB code: 4ZFO)Value of the data The antibody targets the very restrictively expressed tumor marker BCMA for Multiple Myeloma
and potently inhibits tumor growth in mice
 The antibody has an exceptionally high afﬁnity to BCMA (picomolar)
 The high resolution crystal structure of the antibody-BCMA complex reveals a network of water
molecules in the binding interface
 The structure shows how very high afﬁnity can be achieved with a minimal number of direct
protein-protein contactsthe J22.9-xi binding site. A. A view of the binding interaction between BCMA (magenta) and the
y chain (VH, blue) and light chain (VL, yellow). Interface water molecules participating in bridging
ns between BCMA and J22.9-xi are depicted as cyan spheres with a radius of 1.4
Â
e. For clarity only
th the corresponding chain color) and some interface waters (with chain numbers directly on the
in the BCMA DxL loop is shown in space-ﬁlling representation. B. A view looking down on the
ith BCMA removed. The Fab fragment is shown in surface representation with the heavy chain
chain colored yellow. Some of the residues making direct contacts to BCMA are indicated with
C. View as in (B) with interface waters depicted as cyan spheres and labeled as in (A).
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Multiple Myeloma (MM) is an incurable malignancy of antibody-secreting B cells (plasma cells)
with a mean life expectancy of 5 years from diagnosis [1]. We generated a chimeric mouse/human
antibody (J22.9-xi) against CD269 (BCMA), a plasma membrane receptor expressed nearly exclusively
in plasma cells; the antibody shows potent cell killing activity on MM cells in vitro and anti-tumor
activity in vivo. Surface Plasmon Resonance Spectrometry (SPR) measurements gave an exceptionally
high afﬁnity of J22.9-xi for BCMA of 50 pM [2]. Although higher afﬁnity antibody:antigen interactions
have been achieved by protein engineering/selection techniques [3], the J22.9-xi interaction exceeds
the low nanomolar afﬁnity range typical of therapeutic antibodies [4,5] (see also, for example, Her-
ceptin at 5 nM [6] and Rituximab at 8 nM [7]) by approximately 100-fold.
A protruding loop in the antigen BCMA (the DxL loop) with Leu17 at its apex is critical for binding
to the native BCMA ligands, B cell Activating Factor of the TNF Family (BAFF) and A PRoliferation
Inducing Ligand (APRIL) [8], both of which have a hydrophobic cavity that packs tightly around Leu17.Table 1
Water interactions in the J22.9-xi:CD269 complex. The interaction partners are read from left to right across the table, with the
corresponding H-bond distances and thermal displacement (B) factors of the indicated water molecules listed (J22.9-xi:H2O:
CD269). For example, Ser31 from the J22.9-xi light chain participates in a hydrogen bonding interaction with water 409B at a
distance of 2.50 Å and water 409B in turn interacts with Thr32 of CD269 at a distance of 2.65 Å. The data in Table 1 were
generated using the software LigPlot [8] and COOT [11].(sc¼side chain H-bond; mc¼main chain H-bond)
Light Chain (B) H2O CD269 (F) Distance (Å) B (Å2)
Ser31 (sc) 409B Thr32 (sc, mc) 2.50, 2.65 (sc) 24.33
2.50, 3.15 (mc)
409B, 110F Arg27 (sc) 2.65, 2.60, 2.98 24.33, 23.47
409B, 110F Ser30 (sc) 2.50, 2.65, 2.69 24.33, 23.47
Ser31 (mc) 458B, 114F Arg27 (sc) 2.71, 2.75, 2.78 26.48, 28.32
Asn32 (sc) 439B Asp15 (sc) 2.67, 2.88 19.24
439B, 114F Arg27 (sc) 2.67, 2.94, 2.78 19.24, 28.32
486B Ser16 (sc) 2.80, 3.18 15.45
Tyr36 (sc) 522B, 336A, 377A Leu17 (mc) 3.19, 2.90, 2.77, 2.88 14.87, 18.33, 35.33
Ser50 (sc) 439B Asp15 (sc) 3.11, 2.88 19.24
Ser52 (sc) 110F Ser30 (sc) 2.73, 2.69 23.47
110F Arg27 (sc) 2.73, 2.98 23.47
Ser52 (sc) 479B, 103F Ser30 (mc) 2.78, 2.65, 2.94 25.34, 31.49
Ser29 (sc) 2.78, 2.65, 2.54
110F, 409B Thr32 (sc, mc) 2.73, 2.60, 2.65 23.47, 24.33
Gly66 (mc) 409B Thr32 (sc) 2.86, 2.65 24.33
409B, 110F Arg27 (sc) 2.86, 2.60, 2.98 24.33, 23.47
409B, 110F Ser30 (sc) 2.86, 2.60, 2.69 24.33, 23.47
Gln89 (sc) 522B, 336A, 377A Leu17 (mc) 2.92, 2.90, 2.77, 2.88 18.47, 18.33, 35.33
Tyr91 (mc) 111F Ser16 (sc) 2.89, 2.71 32.32
111F, 112F Ser16 (mc) 2.89, 2.79, 2.76 32.32, 23.28
Tyr94 (sc) 112F Ser16 (mc) 3.12, 2.76 23.28
112F, 111F Ser16 (sc) 3.12, 2.79, 2.71 23.28, 32.32
Heavy Chain (A) H2O CD269 (F) Distance (Å) B (Å2)
Trp33 (mc) 421A, 108F Leu17 (mc) 2.98, 2.76, 2.62 16.25, 31.34
418A Leu18 (mc) 2.90, 3.45 19.66
Ser35 (sc) 421A, 108F Leu17 (mc) 2.91, 2.76, 2.62 16.25, 31.34
336A, 377A 2.64, 2.77, 2.88 18.33, 35.33
Trp47 (sc) 336A, 377A Leu17 (mc) 2.96, 2.77, 2.88 18.33, 35.33
Glu50 (sc) 112F Ser16 (mc) 3.21, 2.76 23.28
112F, 111F Ser16 (sc) 3.21, 2.79, 2.71 23.28, 32.32
377A Leu17 (mc) 2.75, 2.88 35.33
377A, 108F Leu17 (mc) 2.75, 2.48, 2.62 35.33, 31.34
Leu99 (mc) 108F Leu17 (mc) 3.26, 2.62 31.34
Tyr101 (mc) 105F Leu18 (mc) 3.50, 2.57 25.20
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e X-ray structure of a J22.9-xi Fab fragment in complex with BCMA shows that J22.9-xi also
targets the DxL loop (Fig. 1A). However, the Leu17 binding cavity in J22.9-xi is substantially larger than
the Leu17 side chain and provides only limited hydrophobic interactions between Leu17 and the VL of
the antibody, primarily with Tyr91; the remainder of the binding cavity is ﬁlled with 6 water
molecules that pack against the side of Leu17 opposite the Tyr91 interaction (Fig. 1A, B and C). This
high afﬁnity interaction comprises few minor direct contacts between the molecules (4 direct
hydrogen bonds and 21 mostly single atom van der Waals contacts) but at least 50 hydrogen bonds
involving waters “bridging” interactions between main chain and side chain atoms; 17 of these water
molecules are directly in the binding interface (Table 1). Thus, the structure shows how high afﬁnity
binding can be achieved with only a small number of direct interactions between the binding
partners.2. Analysis of binding interface
Direct atom to atom contacts between BCMA and the VH and VL of J22.9-xi were identiﬁed using the
PISA interaction server [9]. Direct and indirect hydrogen bonding interactions involving water were
identiﬁed and validated (distance and geometry) from the structure using LigPlot [10] and COOT [11].Acknowledgments
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
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